WMSA
MRNS

Weiss Multi-Strategy Advisers’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,500
Closed -$90K – 543
2015
Q1 		$90K Buy
+2,500
New +$110K ﹤0.01% 421

Other funds holding MRNS

CPV
Canaan Partners VII Westport, Connecticut $32.3M AUM 154.97% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Weiss Multi-Strategy Advisers's MRNS Position: Q2 2015 in Review

Weiss Multi-Strategy Advisers sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q2 2015, closing a stake of 2,500 shares — an estimated $90K sold.

Weiss Multi-Strategy Advisers first reported a position in MRNS in Q1 2015 and held it in 1 quarter. The position peaked at $90K in Q1 2015. 27 funds tracked by Wall St. Rank hold MRNS as of Q2 2015.

  • Weiss Multi-Strategy Advisers reported no remaining Marinus Pharmaceuticals, Inc position as of Q2 2015 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 2,500 Marinus Pharmaceuticals, Inc shares in Q2 2015, an estimated $90K.
  • Weiss Multi-Strategy Advisers first reported a position in Marinus Pharmaceuticals, Inc in Q1 2015 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's Marinus Pharmaceuticals, Inc position peaked at $90K in Q1 2015.
  • 27 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q2 2015.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2015, filed 14 Aug 2015.